12/15-LOX has been shown to be reciprocally regulated by IL-13 (increases) and IFN-γ (decreases) (42), suggesting that 12/15-LOX functions as an immunopathogenic factor in type 2/Th2 high asthma. Here, IL13 is linked to asthma.